KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Boston Scientific (BSX) Operating Income (2016 - 2025)

Boston Scientific (BSX) has disclosed Operating Income for 17 consecutive years, with $825.0 million as the latest value for Q4 2025.

  • Quarterly Operating Income rose 22.22% to $825.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.6 billion through Dec 2025, up 38.8% year-over-year, with the annual reading at $3.6 billion for FY2025, 38.8% up from the prior year.
  • Operating Income hit $825.0 million in Q4 2025 for Boston Scientific, down from $1.0 billion in the prior quarter.
  • In the past five years, Operating Income ranged from a high of $1.0 billion in Q3 2025 to a low of $180.0 million in Q4 2021.
  • Historically, Operating Income has averaged $570.4 million across 5 years, with a median of $536.0 million in 2023.
  • Biggest five-year swings in Operating Income: surged 469.01% in 2021 and later decreased 7.49% in 2022.
  • Year by year, Operating Income stood at $180.0 million in 2021, then surged by 123.33% to $402.0 million in 2022, then skyrocketed by 45.27% to $584.0 million in 2023, then increased by 15.58% to $675.0 million in 2024, then rose by 22.22% to $825.0 million in 2025.
  • Business Quant data shows Operating Income for BSX at $825.0 million in Q4 2025, $1.0 billion in Q3 2025, and $819.0 million in Q2 2025.